Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The CATCH Prostate Cancer Trial: Cabazitaxel And Tasquinimod in Men With Castration-Resistant Heavily Pre-treated Prostate Cancer

NCT01513733 is registered in ClinicalTrials.gov with Andrew J. Armstrong, MD as lead sponsor.

NCT NCT01513733
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01513733 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The CATCH Prostate Cancer Trial: Cabazitaxel And Tasquinimod in Men With Castration-Resistant Heavily Pre-treated Prostate Cancer
Lead sponsor
Andrew J. Armstrong, MD
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2012
Completion date
June 30, 2016
Enrollment
25 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer